From: Germline mutations in a clinic-based series of pregnancy associated breast cancer patients
 | Frequency | Percent |
---|---|---|
Age | ||
 25–29 | 2 | 10% |
 30–34 | 6 | 30% |
 35–39 | 9 | 45% |
 40 and older | 3 | 15% |
Ethnicity | ||
 Greek | 18 | 90% |
 Non-Greek | 2 | 10% |
BMI | ||
  ≤ 24.9 (Normal Weight) | 8 | 40% |
 25.0–29.9 (Overweight) | 7 | 35% |
  ≥ 30.0 (Obese) | 5 | 25% |
Time of Diagnosis | ||
 1st trimester (weeks 1–12) | 1 | 5% |
 2nd trimester (weeks 13–26) | 0 | 0% |
 3rd trimester (weeks 27-end) | 8 | 40% |
 Post-partum (up until 12 months) | 6 | 30% |
 N/A | 5 | 25% |
Number of pregnancy | ||
 1st | 4 | 20% |
 2nd | 6 | 30% |
 3rd | 1 | 5% |
 4th | 1 | 5% |
 N/A | 8 | 40% |